In:
Cancer, Wiley, Vol. 125, No. 3 ( 2019-02), p. 374-381
Abstract:
In a study of administrative claims from a large national insurer, the enactment of parity legislation is associated with modestly lower monthly copayments for exemestane and anastrozole. Lowering these monthly copayments is associated with a decreased risk of endocrine therapy nonadherence.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1